Helius Medical Technologies Stock Buy Hold or Sell Recommendation
| HSDT Stock | USD 0.41 0.02 4.65% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Helius Medical Technologies is 'Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Helius Medical Technologies given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Helius Medical Technologies, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Helius Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Helius and provide practical buy, sell, or hold advice based on investors' constraints. Helius Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Helius |
Execute Helius Medical Buy or Sell Advice
The Helius recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Helius Medical Technologies. Macroaxis does not own or have any residual interests in Helius Medical Technologies or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Helius Medical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Actively responds to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Helius Medical Trading Alerts and Improvement Suggestions
| Helius Medical Techn is way too risky over 90 days horizon | |
| Helius Medical Techn has some characteristics of a very speculative penny stock | |
| Helius Medical Techn appears to be risky and price may revert if volatility continues | |
| Helius Medical Techn has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 644 K. Net Loss for the year was (8.85 M) with loss before overhead, payroll, taxes, and interest of (16 K). | |
| Helius Medical Technologies currently holds about 3.27 M in cash with (10.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. | |
| Helius Medical Techn has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Helius Medical Technologies, Inc. Announces the Establishment of |
Helius Medical Returns Distribution Density
The distribution of Helius Medical's historical returns is an attempt to chart the uncertainty of Helius Medical's future price movements. The chart of the probability distribution of Helius Medical daily returns describes the distribution of returns around its average expected value. We use Helius Medical Technologies price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Helius Medical returns is essential to provide solid investment advice for Helius Medical.
| Mean Return | 0.19 | Value At Risk | -11.54 | Potential Upside | 17.19 | Standard Deviation | 14.24 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Helius Medical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Helius Stock Institutional Investors
The Helius Medical's institutional investors refer to entities that pool money to purchase Helius Medical's securities or originate loans. These institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds.
| Shares | Fedenia Advisers Llc | 2024-12-31 | 100.0 | Advisor Group Holdings, Inc. | 2024-12-31 | 80.0 | Federation Des Caisses Desjardins Du Quebec | 2024-12-31 | 32.0 | Bank Of America Corp | 2024-12-31 | 31.0 | St Germain D J Co Inc | 2024-12-31 | 2.0 | Susquehanna International Group, Llp | 2024-12-31 | 0.0 | The Toronto-dominion Bank | 2024-09-30 | 0.0 | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 0.0 | Armistice Capital, Llc | 2024-09-30 | 0.0 | Virtu Financial Llc | 2024-12-31 | 46.5 K | Ubs Group Ag | 2024-12-31 | 29.5 K |
Helius Medical Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (2.1M) | 7.7M | 3.5M | (9.4M) | (8.4M) | (8.0M) | |
| Free Cash Flow | (11.8M) | (13.4M) | (14.3M) | (10.4M) | (9.4M) | (9.9M) | |
| Other Non Cash Items | (56K) | 82K | (1.4M) | (3.0M) | (3.5M) | (3.7M) | |
| Capital Expenditures | 70K | 56K | 17K | 29K | 26.1K | 24.8K | |
| Net Income | (14.1M) | (18.1M) | (14.1M) | (8.9M) | (8.0M) | (8.4M) | |
| End Period Cash Flow | 3.3M | 11.0M | 14.5M | 5.2M | 6.0M | 7.0M | |
| Investments | (9K) | (56K) | (11K) | (24K) | (27.6K) | (29.0K) | |
| Depreciation | 482K | 312K | 255K | 162K | 186.3K | 153.0K | |
| Change To Netincome | (9.1M) | 3.0M | 4.3M | 813K | 731.7K | 695.1K | |
| Change To Inventory | 4K | (87K) | (111K) | 137K | 157.6K | 165.4K |
Helius Medical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Helius Medical or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Helius Medical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Helius stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.39 | |
β | Beta against Dow Jones | 1.97 | |
σ | Overall volatility | 14.70 | |
Ir | Information ratio | 0.02 |
Helius Medical Volatility Alert
Helius Medical Technologies is displaying above-average volatility over the selected time horizon. Helius Medical Technologies is a potential penny stock. Although Helius Medical may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Helius Medical Technologies. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Helius instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Helius Medical Fundamentals Vs Peers
Comparing Helius Medical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Helius Medical's direct or indirect competition across all of the common fundamentals between Helius Medical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Helius Medical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Helius Medical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Helius Medical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Helius Medical to competition |
| Fundamentals | Helius Medical | Peer Average |
| Return On Equity | -2.6 | -0.31 |
| Return On Asset | -1.13 | -0.14 |
| Operating Margin | (79.80) % | (5.51) % |
| Current Valuation | (1.13 M) | 16.62 B |
| Shares Outstanding | 5.67 M | 571.82 M |
| Shares Owned By Insiders | 0.52 % | 10.09 % |
| Shares Owned By Institutions | 6.63 % | 39.21 % |
| Number Of Shares Shorted | 55.52 K | 4.71 M |
| Price To Earning | (13.85) X | 28.72 X |
| Price To Book | 0.61 X | 9.51 X |
| Price To Sales | 4.61 X | 11.42 X |
| Revenue | 644 K | 9.43 B |
| Gross Profit | (16 K) | 27.38 B |
| EBITDA | (12.11 M) | 3.9 B |
| Net Income | (8.85 M) | 570.98 M |
| Cash And Equivalents | 3.27 M | 2.7 B |
| Cash Per Share | 0.12 X | 5.01 X |
| Total Debt | 57 K | 5.32 B |
| Debt To Equity | 0.03 % | 48.70 % |
| Current Ratio | 2.85 X | 2.16 X |
| Book Value Per Share | 1.04 X | 1.93 K |
| Cash Flow From Operations | (10.42 M) | 971.22 M |
| Short Ratio | 0.10 X | 4.00 X |
| Earnings Per Share | (4.27) X | 3.12 X |
| Target Price | 4.0 | |
| Number Of Employees | 22 | 18.84 K |
| Beta | 1.63 | -0.15 |
| Market Capitalization | 2.31 M | 19.03 B |
| Total Asset | 7.69 M | 29.47 B |
| Retained Earnings | (159.96 M) | 9.33 B |
| Working Capital | 5.56 M | 1.48 B |
| Current Asset | 6.8 M | 9.34 B |
| Current Liabilities | 4.46 M | 7.9 B |
Note: Acquisition by Dane Andreeff of 279715 shares of Helius Medical at 0.7292 subject to Rule 16b-3 [view details]
Helius Medical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Helius . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.0488 | |||
| Daily Balance Of Power | (1.00) | |||
| Rate Of Daily Change | 0.95 | |||
| Day Median Price | 0.4 | |||
| Day Typical Price | 0.4 | |||
| Market Facilitation Index | 0.02 | |||
| Period Momentum Indicator | (0.02) |
About Helius Medical Buy or Sell Advice
When is the right time to buy or sell Helius Medical Technologies? Buying financial instruments such as Helius Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Helius Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Wireless Thematic Idea Now
Wireless
Companies providing wireless technology and communication services. The Wireless theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Wireless Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Helius Stock Analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.